Australia's largest stock trading and investment forum Australia's #1 stock forum

MXR

2.17%

4.5¢ maximus resources limited

Ann: RC drilling commences at Redback gold deposit, page-13

First 13 Last

Share
Profile

Follow
JUJX11

711 Posts.

38

12/08/21

15:36

Post #: 55240343
Share

Originally posted by Sentia717: ↑

aussiepaul72's suggestion is certainly a very sensible one to follow up oddle. MXR is working on becoming a producer. It is presently working on being able to announce a new Mineral Resource Estimate.
I think if you have a look at the Investor Presentation announcement released on June 29th as a starting point in looking over the last eight or so announcements as suggested then that will give you a good guide as to what they are involved with. It is pretty promising for gold and for nickel.

Expand

It's a long time since we had any news sufficiently good to encourage the share price. The milling deal we had to utilize Burbank has collected dust.

MXR Price at posting: 7.9¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BUX

Buxton projects new graphite province discovery at WA Narryer play

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

First 13 Last

Add MXR (ASX) to my watchlist

(20min delay)
Last 4.5¢		Change -0.001(2.17%)		Mkt cap ! $19.25M

Open	High	Low	Value	Volume
4.7¢	4.7¢	4.2¢	$42.78K	958.1K

Buyers (Bids)

No.	Vol.	Price($)
1	78891	4.5¢

Sellers (Offers)

Price($)	Vol.	No.
4.6¢	54339	1

View Market Depth

No.	Vol.	Price($)
1	78891	0.045
1	300000	0.044
1	369531	0.043
2	437620	0.042
1	500000	0.041

Price($)	Vol.	No.
0.046	54339	1
0.047	302980	3
0.048	39560	2
0.049	308920	5
0.050	1050367	3

Last trade - 15.35pm 04/10/2024 (20 minute delay)

MXR (ASX) Chart

Ann: RC drilling commences at Redback gold deposit, page-13

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BCI reaches close of funding facility for salt-first part of Mardie project

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Buxton projects new graphite province discovery at WA Narryer play

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: RC drilling commences at Redback gold deposit, page-13

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BCI reaches close of funding facility for salt-first part of Mardie project

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Buxton projects new graphite province discovery at WA Narryer play

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News